Competition Commission Takes Adcock Ingram Critical Care to Tribunal Over Alleged Excessive Pricing of Dialysis Products
The Competition Commission has referred a case against Adcock Ingram Critical Care (AICC) to the Competition Tribunal over allegations that the company charged excessive prices for critical dialysis products used in the treatment of kidney failure.According to the Commission, the alleged conduct occurred between July 2019 and June 2024 and may constitute a violation of […]
Continue Reading